VASOSEAL HEMOSTASIS FOLLOWING CORONARY INTERVENTIONS WITH ABCIXIMAB

Femoral arteriotomy management using a collagen vascular hemostasis de vice (VasoSeal) was studied in 50 consecutive patients following inter ventional coronary procedures performed with Abciximab (ReoPro), Low d ose weight adjusted or no heparin was employed, The first 25 patients were permitted to sit up after 6 hours with ambulation the following d ay, The second 25 patients were allowed to sit up after I hour and amb ulate after 6 hours. Despite early activity and ambulation, there were no hemorrhagic complications including hematoma, pseudoaneurysm, bloo d transfusion, or surgical repair. Hemoglobin and platelet counts rema ined stable overnight prior to discharge. This pilot study demonstrate s the potential efficacy of VasoSeal in achieving early sheath removal and ambulation in patients undergoing interventional procedures using . (C) 1998 Wiley-Liss, Inc.